T3	Condition 64 78	MRSA infection
T4	Condition-Name 64 78	MRSA infection
E3	Condition:T3 Name:T4
T5	Life-Stage-And-Gender 25 31	Adults
A1	Life-Stage-And-Gender-Type T5 adult
T6	Condition 129 143	breast feeding
T7	Condition-Name 129 143	breast feeding
E6	Condition:T6 Name:T7
T8	Condition 116 125	Pregnancy
T9	Condition-Name 116 125	Pregnancy
E8	Condition:T8 Name:T9
T12	Condition 504 517	HIV infection
T13	Condition-Name 504 517	HIV infection
E12	Condition:T12 Name:T13
T14	Condition 519 547	systemic lupus erythematoses
T15	Condition-Name 519 547	systemic lupus erythematoses
E14	Condition:T14 Name:T15
T16	Eq-Operator 235 236	≥
A2	Eq-Operator-Value T16 GTEQ
T17	Eq-Operator 420 426	within
A3	Eq-Operator-Value T17 LTEQ
T18	Eq-Temporal-Unit 429 433	days
A4	Eq-Temporal-Unit-Value T18 day
T19	Eq-Value 236 237	2
T20	Eq-Value 427 428	7
T21	Eq-Value 640 642	72
T22	Eq-Comparison 235 237	≥2
E15	Eq-Comparison:T22 Operator:T16 Value:T19 Unit:T34 Per:T35
T23	Eq-Comparison 420 433	within 7 days
E16	Eq-Comparison:T23 Operator:T17 Temporal-Unit:T18 Value:T20
T1	Condition 51 54	ill
E1	Condition:T1 Severity:T2
T2	Severity 40 50	critically
A5	Severity-Value T2 severe
T10	And 32 35	who
E2	And:T10 Arg:T5 Arg2:E1
T11	Assertion 79 89	suspection
E4	Assertion:T11 Asserted:E3
A6	Assertion-Type-Value E4 possible
T24	And 55 58	and
E5	And:T24 Arg:E1 Arg2:E3
T25	Or 126 128	or
E7	Or:T25 Arg:E8 Arg2:E6
T26	Allergy 156 163	allergy
E9	Allergy:T26 Name:E10
T27	Drug 174 184	vancomycin
E10	Drug:T27 Name:T28
T28	Drug-Name 174 184	vancomycin
T29	Drug 188 201	ascorbic acid
E11	Drug:T29 Name:T30
T30	Drug-Name 188 201	ascorbic acid
T31	Or 185 187	or
E13	Or:T31 Arg:E10 Arg2:E11
T32	Observation 218 234	serum creatinine
E17	Observation:T32 Name:T33 Eq-Comparison:E15
T33	Observation-Name 218 234	serum creatinine
A7	Observation-Type-Value T33 lab
T34	Eq-Unit 237 239	mg
T35	Eq-Unit 240 242	dl
T36	Drug 274 290	nephrotoxic drug
E18	Drug:T36 Name:T37
T37	Drug-Name 274 290	nephrotoxic drug
T38	Drug-Name 298 313	aminoglycosides
T39	Drug 298 313	aminoglycosides
E19	Drug:T39 Name:T38
T40	Drug 315 329	amphotericin B
E20	Drug:T40 Name:T41
T41	Drug-Name 315 329	amphotericin B
T42	Drug 331 340	cisplatin
E21	Drug:T42 Name:T43
T43	Drug-Name 331 340	cisplatin
T44	Drug 344 366	calcinurine inhibitors
E22	Drug:T44 Name:T45
T45	Drug-Name 344 366	calcinurine inhibitors
T46	Or 341 343	or
E23	Or:T46 Arg:E21 Arg2:E22
R1	Example-Of Arg1:E19 Arg2:E18	
R2	Example-Of Arg1:E20 Arg2:E18	
R3	Example-Of Arg1:E21 Arg2:E18	
R4	Example-Of Arg1:E22 Arg2:E18	
T47	Assertion 374 385	Anticepated
E24	Assertion:T47 Asserted:E25
A8	Assertion-Type-Value E24 hypothetical
T48	Drug 404 419	contrast medium
E25	Drug:T48 Name:T49 Temporality:E16
T49	Drug-Name 404 419	contrast medium
T50	Condition 480 488	diseases
E26	Condition:T50 Name:T51
T51	Condition-Name 480 488	diseases
T52	Condition 496 502	cancer
E27	Condition:T52 Name:T53
T53	Condition-Name 496 502	cancer
T54	Condition 551 571	urinary tract stones
E28	Condition:T54 Name:T55
T55	Condition-Name 551 571	urinary tract stones
T56	Or 548 550	or
E29	Or:T56 Arg:E14 Arg2:E28
R5	Example-Of Arg1:E27 Arg2:E26	
R6	Example-Of Arg1:E12 Arg2:E26	
R7	Example-Of Arg1:E14 Arg2:E26	
R8	Example-Of Arg1:E28 Arg2:E26	
T57	Assertion 579 591	Unlikelyhood
E30	Assertion:T57 Asserted:E31
A9	Assertion-Type-Value E30 hypothetical
T58	Drug 615 626	medications
E31	Drug:T58 Temporality:E32
T59	Eq-Comparison 631 648	at least 72 hours
E32	Eq-Comparison:T59 Temporal-Unit:T61 Operator:T60 Value:T21
T60	Eq-Operator 631 639	at least
A10	Eq-Operator-Value T60 LTEQ
T61	Eq-Temporal-Unit 643 648	hours
A11	Eq-Temporal-Unit-Value T61 hour
